𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Glucocorticoid receptor mRNA in patients with ulcerative colitis: A study of responders and nonresponders to glucocorticosteroid therapy

✍ Scribed by Dr. Lars Flood; Robert Löfberg; Pontus Stierna; Ann-Charlotte Wikström

Book ID
110085954
Publisher
John Wiley and Sons
Year
2001
Tongue
English
Weight
491 KB
Volume
7
Category
Article
ISSN
1078-0998

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Mucosal healing in patients with ulcerat
Mucosal healing in patients with ulcerative colitis during a course of selective leukocytapheresis therapy: A prospective cohort study
✍ Takayuki Yamamoto; Satoru Umegae; Koichi Matsumoto 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 270 KB

Background: During active ulcerative colitis (UC), vast numbers of granulocytes, monocytes/macrophages (GM) infiltrate the mucosal tissue and can potentially exacerbate inflammation and injury. Accordingly, we were interested to see if selective depletion of GM by adsorption (GMA) impacts mucosal he

Open-label study of adalimumab in patien
Open-label study of adalimumab in patients with ulcerative colitis including those with prior loss of response or intolerance to infliximab
✍ Waqqas Afif; Jonathan A. Leighton; Stephen B. Hanauer; Edward V. Loftus Jr; Will 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB 👁 1 views

## Background: The aim of this study was to assess the clinical benefit and tolerability of adalimumab, a fully human monoclonal antibody to tumor necrosis factor (TNF), in patients with ulcerative colitis (UC). Methods: Patients with active UC, including those who had lost response or developed

The INSPIRE study: Are different persona
The INSPIRE study: Are different personality traits related to disease-specific quality of life (IBDQ) in distressed patients with ulcerative colitis and Crohn's disease?
✍ Birgitte Boye; Jorgen Jahnsen; Kjell Mokleby; Siv Leganger; Günter Jantschek; In 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 105 KB 👁 2 views

## Background: To explore the relationship between personality and disease-specific quality of life [Inflammatory Bowel Disease Questionnaire (IBDQ)] in distressed [Perceived Stress Questionnaire (PSQ)] patients with ulcerative colitis (UC) and Crohn's disease (CD). Methods: Included in the study

Safety and tolerability of a modified fi
Safety and tolerability of a modified filter-type device for leukocytapheresis using ACD-A as anticoagulant in patients with mild to moderately active ulcerative colitis. Results of a pilot study
✍ Vladislaw Muratov; Joachim Lundahl; Aleksandra Mandic-Havelka; Kerstin Elvin; Åk 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 117 KB

## Abstract Cellsorba™ is a medical device for leukocytapheresis (LCAP) treatment of ulcerative colitis (UC). Cellsorba™ EX Global type has been developed from Cellsorba E for intended use with ACD‐A as anticoagulant. We evaluated safety and efficacy of the modified Cellsorba using ACD‐A in a pilot